All Posts: Parkinson's disease
22 Articles
- GUMC Stories
School of Medicine’s Rebekah Evans Encourages Collaboration in Research and Teaching
Rebekah Evans, PhD, assistant professor in neuroscience, researches the neural circuitry involved in the development of Parkinson’s disease while mentoring and training…
February 17, 2026
- News Release
Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease
WASHINGTON (Friday, November 12, 2021) — In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular…
November 12, 2021
- News Release
Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and…
December 16, 2019
- News Release
Novel Agent Flips on ‘Garbage Disposal’ in Neurons, Eliminating Toxic Brain Proteins in Mice
CHICAGO (October 22, 2019) — Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in…
October 22, 2019
- GUMC Stories
Shedding Light on Lewy Body Disease
(May 30, 2019) — Though many people are familiar with Parkinson’s and Alzheimer’s diseases, fewer have heard of Lewy body dementia, a neurodegenerative disorder with…
May 30, 2019
- GUMC Stories
Impacted by Parkinson’s Disease, Three Couples Plan to Leave a Lasting Legacy to Support Research
(April 26, 2019) — When someone is diagnosed with an incurable, life-changing disease like Parkinson’s, they usually have many questions about how it will affect their life…
April 26, 2019
- News Release
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in…
March 12, 2019
- GUMC Stories
Training the Next Generation of Researchers in Movement Disorders
(February 8, 2019) — After she first developed a tremor in her right hand, years went by before Pam Cota was diagnosed with Parkinson’s disease by Fernando Pagan, MD (M&…
February 8, 2019
- News Release
Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
MEDIA CONTACT (ONLY, PLEASE):Karen Teberkm463@georgetown.edu WASHINGTON (November 14, 2018) — A defining feature of Parkinson’s disease is the clumps of alpha-synuclein…
November 14, 2018
- News Release
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that…
June 27, 2017